The National Institutes of Health FY 2016-2020 Strategic Plan To Advance Research on the Health and Well-Being of Sexual and Gender Minorities (SGM) Request for Comments, 59169-59170 [2015-25026]
Download as PDF
<![CDATA[
59169
Federal Register / Vol. 80, No. 190 / Thursday, October 1, 2015 / Notices
other than their time. The total
estimated annualized burden hours are
16,100.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Customer satisfaction surveys ..........
In-Depth Interviews (IDIs) or Small
Discussion Groups.
Individual Brief Interviews .................
Focus Groups ...................................
Pilot testing surveys ..........................
Conferences and Training Pre- and
Post-surveys.
Web site or Software Usability Tests
Private Sector ...................................
Private Sector ...................................
Total ...........................................
1
1
30/60
90/60
12,500
750
...................................
...................................
...................................
...................................
200
1,000
200
1,000
1
1
1
1
15/60
2
30/60
30/60
50
2,000
100
500
Private Sector ...................................
100
1
2
200
...........................................................
28,000
........................
........................
16,100
Private
Private
Private
Private
Sector
Sector
Sector
Sector
Initiatives, Office of the Director, NIH,
Building 1, Room 257, 1 Center Drive,
Bethesda, MD 20892, Telephone: 301–
451–2055, Email: karen.parker@nih.gov.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2015–25005 Filed 9–30–15; 8:45 am]
BILLING CODE 4140–01–P
Background
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
The National Institutes of Health FY
2016–2020 Strategic Plan To Advance
Research on the Health and Well-Being
of Sexual and Gender Minorities (SGM)
Request for Comments
The National Institutes of
Health (NIH) is developing a strategic
plan to guide the agency’s efforts and
priorities in SGM research over the next
five years (2016–2020). The purpose of
this notice is to seek input from
researchers in academia and industry,
health care professionals, patient
advocates and health advocacy
organizations, scientific or professional
organizations, public agencies, and
other interested members of the public
about proposed goals and objectives for
advancing research and other researchrelated activities with SGM populations.
Specific organizations, such as advocacy
or professional groups are encouraged to
submit a single response that reflects the
views of their organization and
membership as a whole.
DATES: To ensure consideration of your
comments, responses must be received
by November 2, 2015.
ADDRESSES: Responses to this notice
must be submitted electronically by
email to sgmhealthresearch@od.nih.gov.
FOR FURTHER INFORMATION CONTACT: Dr.
Karen Parker, Division of Program
Coordination, Planning, and Strategic
mstockstill on DSK4VPTVN1PROD with NOTICES6
SUMMARY:
21:04 Sep 30, 2015
Total annual
burden hours
25,000
500
Dated: September 25, 2015.
Dione Washington,
Project Clearance Liaison, NIAID, NIH.
VerDate Sep<11>2014
Average
burden per
response
(in hours)
Number of
responses per
respondent
Number of
respondents
Form name
Jkt 238001
The NIH developed this Strategic Plan
to Advance Research on the Health and
Wellbeing of Sexual and Gender
Minorities (SGM) (https://edi.nih.gov/
sgm/research/sgm-strategic-plan.pdf)
after substantive analysis and
integration of portfolio analyses,
community input, inter- and intraagency collaborations, and
recommendations from the NIHcommissioned Institute of Medicine
report, The Health of Lesbian, Gay,
Bisexual, and Transgender (LGBT)
People: Building a Foundation for Better
Understanding, released in 2011.
The NIH SGM Strategic Research Plan
promotes and supports the advancement
of basic, clinical, and behavioral and
social sciences research to improve the
health of people whose sexual
orientations, gender identities/
expressions, and/or reproductive
development vary from traditional,
societal, cultural, or physiological
norms. In each of these areas, the NIH
will coordinate with the NIH intramural
and extramural program directors and
researchers to ensure the advancement
of SGM-focused research efforts.
The NIH anticipates that this 5 year
plan, which will cover the years 2016–
2020, will provide the NIH with a
framework for progress in this area, and
that the research that results from this
plan will lay a foundation for improved
health and well-being amongst a group
of diverse SGM individuals whose
health needs have not traditionally
received strong attention from the
research community.
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Information Requested
This notice invites public comment
and input on the proposed goals and
objectives of the strategic plan. We ask
that you consider cross-cutting research
opportunities, and/or needs that could
have the greatest benefit for advancing
SGM health.
To inform implementation of the SGM
strategic plan, input is being sought on
each of the areas identified below.
(1) Specific priority areas of research
in SGM populations.
(2) Goals and objectives outlined in
the plan.
(3) Any additional comments or
information you think would be useful
to the NIH about the proposed 2016–
2020 Strategic Plan to Advance
Research on the Health and Well-being
of Sexual and Gender Minorities.
To ensure consideration of your
comments, responses must be received
by November 2, 2015.
General Information
All of the following fields in the
response are optional and voluntary.
Any personal identifiers will be
removed when responses are compiled.
Proprietary, classified, confidential, or
sensitive information should not be
included in your response. This notice
is for planning purposes only and is not
a solicitation for applications or an
obligation on the part of the United
States (U.S.) government to provide
support for any ideas identified in
response to it. Please note that the U.S.
government will not pay for the
preparation of any comment submitted
or for its use of that comment.
Please indicate if you are one of the
following: Grantee, administrator,
student, patient advocate, Dean/or
Institutional administrator, NIH
employee, or other. If you are an
E:\FR\FM\01OCN1.SGM
01OCN1
59170
Federal Register / Vol. 80, No. 190 / Thursday, October 1, 2015 / Notices
investigator, please indicate your career
level and main area of research interest,
including whether the focus is clinical
or basic. If you are a member of a
particular advocacy or professional
organization, please indicate the name
and primary focus of the organization
(e.g., research support, patient care, etc.)
and whether you are responding on
behalf of your organization (if yes,
please indicate your position within the
organization). Please provide your name
and email address.
Privacy Act Notification Statement:
We are requesting your comments for
the 2016–2020 National Institutes of
Health Sexual and Gender Minority
Strategic Plan. The information you
provide may be disclosed to the NIH
senior staff and those serving on the
SGM Research Coordinating Committee
and to contractors working on our
behalf. Submission of this information
is voluntary. However, the information
you provide will help to categorize
responses by scientific area of expertise,
organizational entity or professional
affiliation.
Collection of this information is
authorized under 42 U.S.C. 203, 24 1,
2891–1 and 44 U.S.C. 310 I and Section
30 l and 493 of the Public Health
Service Act regarding the establishment
of the National Institutes of Health, its
general authority to conduct and fund
research and to provide training
assistance, and its general authority to
maintain records in connection with
these and its other functions.
Dated: September 24, 2015.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2015–25026 Filed 9–30–15; 8:45 am]
BILLING CODE 4140–01–P
mstockstill on DSK4VPTVN1PROD with NOTICES6
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
Jkt 238001
Dated: September 24, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
National Institutes of Health
21:04 Sep 30, 2015
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Peer Review Meeting.
Date: October 23, 2015.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, Room
3F21A, 5601 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: Maja Maric, Ph.D.,
Scientific Review Officer Scientific Review
Program, Division of Extramural Activities,
Room # 3F21A National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20852, (240) 669–5025,
maja.maric@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Global Infectious Disease
Research Administration Development
Award for Low- and Middle-Income Country
Institutions (G11).
Date: October 28, 2015.
Time: 11:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health Room
3C100, 5601 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: Louis A. Rosenthal, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Rm 3G42B, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC–79823,
Bethesda, MD 20892–9823, (240) 669–5070,
rosenthalla@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
[FR Doc. 2015–24824 Filed 9–30–15; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Current List of HHS-Certified
Laboratories and Instrumented Initial
Testing Facilities Which Meet Minimum
Standards To Engage in Urine Drug
Testing for Federal Agencies
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS) notifies federal
agencies of the laboratories and
Instrumented Initial Testing Facilities
SUMMARY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
(IITF) currently certified to meet the
standards of the Mandatory Guidelines
for Federal Workplace Drug Testing
Programs (Mandatory Guidelines). The
Mandatory Guidelines were first
published in the Federal Register on
April 11, 1988 (53 FR 11970), and
subsequently revised in the Federal
Register on June 9, 1994 (59 FR 29908);
September 30, 1997 (62 FR 51118);
April 13, 2004 (69 FR 19644); November
25, 2008 (73 FR 71858); December 10,
2008 (73 FR 75122); and on April 30,
2010 (75 FR 22809).
A notice listing all currently HHScertified laboratories and IITFs is
published in the Federal Register
during the first week of each month. If
any laboratory or IITF certification is
suspended or revoked, the laboratory or
IITF will be omitted from subsequent
lists until such time as it is restored to
full certification under the Mandatory
Guidelines.
If any laboratory or IITF has
withdrawn from the HHS National
Laboratory Certification Program (NLCP)
during the past month, it will be listed
at the end and will be omitted from the
monthly listing thereafter.
This notice is also available on the
Internet at https://www.samhsa.gov/
workplace.
FOR FURTHER INFORMATION CONTACT:
Giselle Hersh, Division of Workplace
Programs, SAMHSA/CSAP, Room 7–
1051, One Choke Cherry Road,
Rockville, Maryland 20857; 240–276–
2600 (voice), 240–276–2610 (fax).
SUPPLEMENTARY INFORMATION: The
Mandatory Guidelines were initially
developed in accordance with Executive
Order 12564 and section 503 of Pub. L.
100–71. The ‘‘Mandatory Guidelines for
Federal Workplace Drug Testing
Programs,’’ as amended in the revisions
listed above, requires strict standards
that laboratories and IITFs must meet in
order to conduct drug and specimen
validity tests on urine specimens for
federal agencies.
To become certified, an applicant
laboratory or IITF must undergo three
rounds of performance testing plus an
on-site inspection. To maintain that
certification, a laboratory or IITF must
participate in a quarterly performance
testing program plus undergo periodic,
on-site inspections.
Laboratories and IITFs in the
applicant stage of certification are not to
be considered as meeting the minimum
requirements described in the HHS
Mandatory Guidelines. A HHS-certified
laboratory or IITF must have its letter of
certification from HHS/SAMHSA
(formerly: HHS/NIDA), which attests
that it has met minimum standards.
E:\FR\FM\01OCN1.SGM
01OCN1
]]>Agencies
[Federal Register Volume 80, Number 190 (Thursday, October 1, 2015)]
[Notices]
[Pages 59169-59170]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-25026]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
The National Institutes of Health FY 2016-2020 Strategic Plan To
Advance Research on the Health and Well-Being of Sexual and Gender
Minorities (SGM) Request for Comments
SUMMARY: The National Institutes of Health (NIH) is developing a
strategic plan to guide the agency's efforts and priorities in SGM
research over the next five years (2016-2020). The purpose of this
notice is to seek input from researchers in academia and industry,
health care professionals, patient advocates and health advocacy
organizations, scientific or professional organizations, public
agencies, and other interested members of the public about proposed
goals and objectives for advancing research and other research-related
activities with SGM populations. Specific organizations, such as
advocacy or professional groups are encouraged to submit a single
response that reflects the views of their organization and membership
as a whole.
DATES: To ensure consideration of your comments, responses must be
received by November 2, 2015.
ADDRESSES: Responses to this notice must be submitted electronically by
email to sgmhealthresearch@od.nih.gov.
FOR FURTHER INFORMATION CONTACT: Dr. Karen Parker, Division of Program
Coordination, Planning, and Strategic Initiatives, Office of the
Director, NIH, Building 1, Room 257, 1 Center Drive, Bethesda, MD
20892, Telephone: 301-451-2055, Email: karen.parker@nih.gov.
SUPPLEMENTARY INFORMATION:
Background
The NIH developed this Strategic Plan to Advance Research on the
Health and Wellbeing of Sexual and Gender Minorities (SGM) (https://edi.nih.gov/sgm/research/sgm-strategic-plan.pdf) after substantive
analysis and integration of portfolio analyses, community input, inter-
and intra-agency collaborations, and recommendations from the NIH-
commissioned Institute of Medicine report, The Health of Lesbian, Gay,
Bisexual, and Transgender (LGBT) People: Building a Foundation for
Better Understanding, released in 2011.
The NIH SGM Strategic Research Plan promotes and supports the
advancement of basic, clinical, and behavioral and social sciences
research to improve the health of people whose sexual orientations,
gender identities/expressions, and/or reproductive development vary
from traditional, societal, cultural, or physiological norms. In each
of these areas, the NIH will coordinate with the NIH intramural and
extramural program directors and researchers to ensure the advancement
of SGM-focused research efforts.
The NIH anticipates that this 5 year plan, which will cover the
years 2016-2020, will provide the NIH with a framework for progress in
this area, and that the research that results from this plan will lay a
foundation for improved health and well-being amongst a group of
diverse SGM individuals whose health needs have not traditionally
received strong attention from the research community.
Information Requested
This notice invites public comment and input on the proposed goals
and objectives of the strategic plan. We ask that you consider cross-
cutting research opportunities, and/or needs that could have the
greatest benefit for advancing SGM health.
To inform implementation of the SGM strategic plan, input is being
sought on each of the areas identified below.
(1) Specific priority areas of research in SGM populations.
(2) Goals and objectives outlined in the plan.
(3) Any additional comments or information you think would be
useful to the NIH about the proposed 2016-2020 Strategic Plan to
Advance Research on the Health and Well-being of Sexual and Gender
Minorities.
To ensure consideration of your comments, responses must be
received by November 2, 2015.
General Information
All of the following fields in the response are optional and
voluntary. Any personal identifiers will be removed when responses are
compiled. Proprietary, classified, confidential, or sensitive
information should not be included in your response. This notice is for
planning purposes only and is not a solicitation for applications or an
obligation on the part of the United States (U.S.) government to
provide support for any ideas identified in response to it. Please note
that the U.S. government will not pay for the preparation of any
comment submitted or for its use of that comment.
Please indicate if you are one of the following: Grantee,
administrator, student, patient advocate, Dean/or Institutional
administrator, NIH employee, or other. If you are an
[[Page 59170]]
investigator, please indicate your career level and main area of
research interest, including whether the focus is clinical or basic. If
you are a member of a particular advocacy or professional organization,
please indicate the name and primary focus of the organization (e.g.,
research support, patient care, etc.) and whether you are responding on
behalf of your organization (if yes, please indicate your position
within the organization). Please provide your name and email address.
Privacy Act Notification Statement: We are requesting your comments
for the 2016-2020 National Institutes of Health Sexual and Gender
Minority Strategic Plan. The information you provide may be disclosed
to the NIH senior staff and those serving on the SGM Research
Coordinating Committee and to contractors working on our behalf.
Submission of this information is voluntary. However, the information
you provide will help to categorize responses by scientific area of
expertise, organizational entity or professional affiliation.
Collection of this information is authorized under 42 U.S.C. 203,
24 1, 2891-1 and 44 U.S.C. 310 I and Section 30 l and 493 of the Public
Health Service Act regarding the establishment of the National
Institutes of Health, its general authority to conduct and fund
research and to provide training assistance, and its general authority
to maintain records in connection with these and its other functions.
Dated: September 24, 2015.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2015-25026 Filed 9-30-15; 8:45 am]
BILLING CODE 4140-01-P
